chr19-19096150-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_178526.5(SLC25A42):c.26C>T(p.Pro9Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00142 in 1,613,614 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. P9P) has been classified as Likely benign.
Frequency
Consequence
NM_178526.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC25A42 | NM_178526.5 | c.26C>T | p.Pro9Leu | missense_variant | 2/8 | ENST00000318596.8 | |
SLC25A42 | NM_001321544.2 | c.26C>T | p.Pro9Leu | missense_variant | 2/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC25A42 | ENST00000318596.8 | c.26C>T | p.Pro9Leu | missense_variant | 2/8 | 1 | NM_178526.5 | P1 | |
SLC25A42 | ENST00000594070.5 | n.208C>T | non_coding_transcript_exon_variant | 1/5 | 2 | ||||
SLC25A42 | ENST00000597661.5 | n.89C>T | non_coding_transcript_exon_variant | 2/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00119 AC: 181AN: 151640Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000944 AC: 237AN: 251190Hom.: 0 AF XY: 0.000957 AC XY: 130AN XY: 135826
GnomAD4 exome AF: 0.00145 AC: 2117AN: 1461854Hom.: 2 Cov.: 31 AF XY: 0.00138 AC XY: 1005AN XY: 727230
GnomAD4 genome AF: 0.00120 AC: 182AN: 151760Hom.: 0 Cov.: 32 AF XY: 0.00116 AC XY: 86AN XY: 74196
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 25, 2022 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: Ormond2020[Thesis]) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 25, 2022 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 9 of the SLC25A42 protein (p.Pro9Leu). This variant is present in population databases (rs117940121, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with SLC25A42-related conditions. ClinVar contains an entry for this variant (Variation ID: 1353162). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 29, 2021 | The c.26C>T (p.P9L) alteration is located in exon 2 (coding exon 1) of the SLC25A42 gene. This alteration results from a C to T substitution at nucleotide position 26, causing the proline (P) at amino acid position 9 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at